Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OSIMERTINIB vs OXITRIPTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OSIMERTINIB vs OXITRIPTAN: Safety Overview

Metric OSIMERTINIB OXITRIPTAN
Total FAERS Reports 27,750 100
Deaths Reported 12,456 5
Death Rate 44.9% 5.0%
Hospitalizations 5,277 34
Average Patient Age 68.2 yrs 52.2 yrs
% Female Patients 66.0% 58.6%
FDA Approval Date Nov 13, 2015 N/A
Manufacturer AstraZeneca Pharmaceuticals LP Energique, Inc.
Route ORAL ORAL
Marketing Status Prescription N/A